What is Orphan Pharmacy Services?
Orphan Pharmacy Services, previously known as Evergreen Pharma Services, operates as a Clinical Trial Services and Support Organization. The company partners with academic institutions and manufacturers to facilitate patient and provider assistance. Its core offerings encompass HUB operations, comprehensive clinical trial management, and the support of expanded access programs. Orphan Pharmacy Services also develops customized programs tailored to specific patient demographic needs, including CRO management, data reporting, patient assistance, and compassionate care management. A key objective is to ensure a fluid transition from clinical trial phases to commercial product availability, specifically addressing the complex requirements of patients with rare diseases.
How much funding has Orphan Pharmacy Services raised?
Orphan Pharmacy Services has raised a total of $82K across 1 funding round:
Debt
$82K
Debt (2021): $82K with participation from PPP
Key Investors in Orphan Pharmacy Services
PPP
Public-Private Partnership
What's next for Orphan Pharmacy Services?
With the recent influx of substantial expansion capital, Orphan Pharmacy Services is poised for significant operational scaling and market penetration. The company's strategic focus on rare disease patient populations and its comprehensive service suite, including HUB operations and expanded access programs, position it favorably within the growing clinical trial services market. Future growth is likely to involve expanding its service offerings, forging new partnerships with pharmaceutical manufacturers, and potentially increasing its geographic reach to serve a broader patient base. This financing round signals investor confidence in Orphan Pharmacy Services' business model and its capacity to address unmet needs in clinical research and patient support.
See full Orphan Pharmacy Services company page
